Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation

    HLA 1-locus-mismatched unrelated donors (1MMUD) have been used in allogeneic hematopoietic stem cell transplantation (allo-HCT) for patients who lack an HLA-matched donor. We retrospectively analyzed 3313 pati...

    K Kawamura, J Kanda, S Fuji, M Murata, K Ikegame, K Yoshioka in Bone Marrow Transplantation (2017)

  2. No Access

    Article

    GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia

    To investigate better GVHD prophylaxis in reduced intensity conditioning umbilical cord blood transplantation (RIC-UCBT), we compared transplant outcomes after UCBT among GvHD prophylaxes using the registry da...

    S Terakura, Y Kuwatsuka, S Yamasaki, A Wake, J Kanda in Bone Marrow Transplantation (2017)

  3. No Access

    Article

    Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation

    The effect of graft-versus-host disease (GVHD) on transplant outcomes after unrelated cord blood transplantation (UCBT) has not been fully elucidated. We analyzed the impact of acute and chronic GVHD on outcom...

    J Kanda, Y Morishima, S Terakura, A Wake, N Uchida, S Takahashi, Y Ono in Leukemia (2017)

  4. No Access

    Article

    Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation

    Hepatic acute GvHD (aGvHD) is associated with high mortality owing to poor response to immunosuppressive therapy. The pathogenesis of hepatic aGvHD differs from that of other lesions, and specific risk factors...

    Y Arai, J Kanda, H Nakasone, T Kondo, N Uchida, T Fukuda in Bone Marrow Transplantation (2016)

  5. No Access

    Article

    Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases

    We compared the expected medical costs of empirical and preemptive treatment strategies for invasive fungal infection in neutropenic patients with hematological diseases. Based on the results of two clinical t...

    S.-I. Kimura, T. Murata, Y. Akahoshi in European Journal of Clinical Microbiology … (2015)

  6. No Access

    Article

    Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation

    The impact of the conditioning intensity and TBI on acute GVHD (aGVHD) is still a matter of debate. We analyzed 6848 adult recipients who received allogeneic hematopoietic cell transplants (HCT) between 2006 a...

    H Nakasone, T Fukuda, J Kanda, T Mori, S Yano, T Kobayashi in Bone Marrow Transplantation (2015)

  7. Article

    Open Access

    Decision analysis for donor selection in stem cell transplantation—HLA-8/8 allele-matched unrelated donor vs HLA-1 AG mismatched related donor

    Risk of relapse during the unrelated donor coordination period biases comparisons between allogeneic hematopoietic stem cell transplantation from an HLA 8 of 8 allele-matched unrelated donor (8/8 MUD) and that...

    J Kanda, S Fuji, S Kato, A Takami, J Tanaka, K Miyamura, K Ohashi in Blood Cancer Journal (2014)

  8. No Access

    Article

    Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT

    In unrelated hematopoietic SCT (HSCT), HLA allele mismatch has been shown to have a significant role. To clarify the importance of HLA allele mismatch in the GVH direction in related HSCT, we retrospectively e...

    S Fuji, J Kanda, S Kato, K Ikegame, S Morishima, T Miyamoto in Bone Marrow Transplantation (2014)

  9. No Access

    Article

    Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation

    We previously reported that the baseline C-reactive protein level did not predict infectious events after hematopoietic cell transplantation (HCT). Procalcitonin (PCT) has recently emerged as a powerful biomar...

    M Sato, H Nakasone, K Terasako-Saito, K Sakamoto, R Yamazaki in Bone Marrow Transplantation (2014)

  10. No Access

    Article

    Risk factors and organ involvement of chronic GVHD in Japan

    Few studies have evaluated the risk factors for chronic GVHD and organ involvement associated with different graft types, including unrelated cord blood (U-CB). We retrospectively studied 4818 adult patients w...

    J Kanda, H Nakasone, Y Atsuta, T Toubai, H Yokoyama in Bone Marrow Transplantation (2014)

  11. No Access

    Article

    Single-cell T-cell receptor-β analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT

    Cellular immunity is important for the control of CMV infection after allogeneic hematopoietic cell transplantation (Allo-HCT). However, the actual in vivo dynamics of CMV-specific cytotoxic T cell (CMV-CTL) clon...

    H Nakasone, Y Tanaka, R Yamazaki, K Terasako, M Sato in Bone Marrow Transplantation (2014)

  12. No Access

    Article

    Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone

    Chemotherapy plus G-CSF (C+G) and G-CSF alone are two of the most common methods used to mobilize CD34+ cells for autologous hematopoietic SCT (AHSCT). In order to compare and determine the real-world outcomes an...

    A D Sung, D T Grima, L M Bernard, S Brown, G Carrum in Bone Marrow Transplantation (2013)

  13. No Access

    Article

    Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment

    High fevers and/or rashes prior to neutrophil engraftment are frequently observed after umbilical cord blood (UCB) transplantation, and the condition is referred to as pre-engraftment syndrome (PES). Few studi...

    J Kanda, L Kaynar, Y Kanda, V K Prasad, S H Parikh, L Lan in Bone Marrow Transplantation (2013)

  14. No Access

    Article

    Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT

    Various biomarkers have been investigated with regard to their ability to predict the outcome of allogeneic hematopoietic SCT (HSCT). In this study, we retrospectively reviewed 90 recipients who received HSCT ...

    M Sato, H Nakasone, K Oshima, Y Ishihara, H Wada, K Sakamoto in Bone Marrow Transplantation (2013)

  15. No Access

    Article

    Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction

    Little information is available regarding whether an unrelated cord blood (UCB) unit or a related donor with a 1-antigen mismatch at the HLA-A, HLA-B or HLA-DR locus in the graft-versus-host direction (RD/1AG-...

    J Kanda, T Ichinohe, S Kato, N Uchida, S Terakura, T Fukuda, M Hidaka, Y Ueda in Leukemia (2013)

  16. No Access

    Article

    Hyperbilirubinemia in the early phase after allogeneic HSCT: prognostic significance of the alkaline phosphatase/total bilirubin ratio

    Hyperbilirubinemia in the early phase after allogeneic hematopoietic SCT (HSCT) is due to various causes. One of the most important causes of hyperbilirubinemia is veno-occlusive disease/sinusoidal obstructive...

    M Ashizawa, K Oshima, H Wada, Y Ishihara, K Kawamura in Bone Marrow Transplantation (2013)

  17. No Access

    Article

    Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation

    Primary graft failure after allogeneic hematopoietic cell transplantation is a life-threatening complication. A shortened conditioning regimen may reduce the risk of infection and increase the chance of surviv...

    J Kanda, M E Horwitz, G D Long, C Gasparetto, K M Sullivan in Bone Marrow Transplantation (2012)

  18. No Access

    Article

    Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation

    Although fluoroquinolones or other antibiotics are commonly used to prevent bacterial infections after hematopoietic cell transplantation (HCT), because of the growing presence of multidrug-resistant microorga...

    J Kanda, C Mizumoto, T Ichinohe, H Kawabata, T Saito in Bone Marrow Transplantation (2011)

  19. No Access

    Article

    Impact of discontinuing fluoroquinolone prophylaxis on early mortality after allogeneic marrow or peripheral blood SCT with myeloablative conditioning

    J Kanda, T Ichinohe, T Saito, K Yamashita, T Kondo in Bone Marrow Transplantation (2010)

  20. No Access

    Article

    Long-term survival after HLA-haploidentical SCT from noninherited maternal antigen-mismatched family donors: impact of chronic GVHD

    J Kanda, T Ichinohe, C Shimazaki, M Hamaguchi, A Watanabe in Bone Marrow Transplantation (2009)

previous disabled Page of 2